Clearside Biomedical (CLSD) Misses Q1 EPS by 2c

Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Surya Oil & Gas faces lawsuit over alleged oral agreement
• Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield